In particular, reductions in peripheral CD4+ T lymphocytes are commonly observed in advanced cases of pancreatic cancer, melanoma, non-Hodgkin lymphoma, sarcoma, hepatocellular carcinoma, and breast cancer [32]. The gene discussed is CD4; the disease is pancreatic neoplasm.